Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Translational Stroke Research
Published in: Translational Stroke Research 2/2010

01-06-2010 | Original Article

Magnesium Sulfate Treatment Improves Outcome in Patients with Subarachnoid Hemorrhage: A Meta-analysis Study

Authors: Bin Huang, Nikan H. Khatibi, Linyan Tong, Pengcheng Yan, Peng Xie, John H. Zhang

Published in: Translational Stroke Research | Issue 2/2010

Login to get access

Abstract

The objective of this study was to elucidate the role of magnesium sulfate in patients with subarachnoid hemorrhagic (SAH) brain injury. Studies for the meta-analysis were identified from PubMed (1966–2009), Embase (1980–2009), and two Chinese journals (1989–2009). Paper selection was based on randomized controlled trials comparing magnesium sulfate to placebo treatment in patients with SAH. Two independent review authors extracted the data and assessed trial quality. Meta-analysis was performed using the Cochrane Review Manager software. Five trials involving 482 patients were included in the review. Magnesium sulfate reduced the risk of poor outcome and reduced the occurrence of delayed cerebral ischemia. In the treatment groups, relative risk for poor outcome was 0.73 (CI 0.57–0.93) and 0.66 (CI 0.47–0.92) for delayed cerebral ischemia. Case fatality assessment at 3 to 6 months did not show statistically significant data (relative risk 0.88, CI 0.61–1.29). Magnesium sulfate appears to be an effective treatment option in the management of SAH. Further clinical trials are needed before magnesium sulfate can become a routine treatment for SAH.
Literature
1.
de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of subarachnoid hemorrhage: a systematic review with emphasis on region, age, gender and time trends. Neurol Neurosurg Psychiatry. 2007;78(12):1365–72.CrossRef
2.
Hop JW, Rinkel GJE, Algra A, et al. Case fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28:660–4.PubMed
3.
Schievink WI et al. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology. 1995;45(5):871–4.PubMed
4.
Zubkov AY et al. Medical management of cerebral vasospasm: present and future. Neurol Res. 2009;31(6):626–31 (Epub 3 Dec 2008).PubMedCrossRef
5.
Muir KW et al. Dose optimization of intravenous magnesium sulfate after acute stroke. Stroke. 1998;29(5):918–23.PubMed
6.
van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;27:306–18.CrossRef
7.
Brilstra EH, Rinkel GJ, Algra A, et al. Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology. 2000;55:1656–60.PubMed
8.
Roos YB, de Haan RJ, Beenen LF, et al. Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: a prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry. 2000;68:337–41.PubMedCrossRef
9.
Naidu S, Payne AJ, Moodley J, et al. Randomised study assessing the effect of phenytoin and magnesium sulphate on maternal cerebral circulation in eclampsia using transcranial Doppler ultrasound. Br J Obstet Gynaecol. 1996;103:111–6.PubMed
10.
Sadeh MS. Action of magnesium sulfate in the treatment of preeclampsia–eclampsia. Stroke. 1989;20:1273–5.PubMed
11.
Boet R, Chan MT, Poon WS, et al. Intravenous magnesium sulfate to improve outcome after aneurysmal subarachnoid hemorrhage: interim report from a pilot study. Acta Neurochir Suppl. 2005;95:263–4.PubMedCrossRef
12.
Muroi C, Terzic A, Fortunati M, et al. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial. Surg Neurol. 2008;69(1):33–9.PubMedCrossRef
13.
van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011–5.PubMedCrossRef
14.
Veyna RS, Seyfried D, Burke DG, et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. Journal of Neurosurgery. 2002;96:510–4.PubMedCrossRef
15.
Wong GKC, Chan MTV, et al. Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study. Journal of Neurosurgery and Anesthesiology. 2006;18(2):142–8.CrossRef
16.
Johnson JW, Ascher P. Voltage-dependent block by intracellular Mg2+ of N-methyl-d-aspartate-activated channels. Biophys J. 1990;57:1085–90.PubMedCrossRef
17.
Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci. 1984;4:1884–91.PubMed
18.
Zhang L, Rzigalinski BA, Ellis EF, et al. Reduction of voltage dependent Mg2+ blockade of NMDA current in mechanically injured neurons. Science. 1996;274:1921–3.PubMedCrossRef
19.
Muir KW. New experimental and clinical data on the efficacy of pharmacological magnesium sulfate infusions in cerebral infarct. Magnes Res. 1998;11:43–56.PubMed
20.
Perales AJ, Torregrosa G, Salom JB. In vivo and in vitro effects of magnesium sulfate in the cerebrovascular bed of the goat. Am J Obstet Gynecol. 1991;165:1534–8.PubMed
21.
Alborch E, Salom HB, Perales AJ. Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries. Eur J Pharmacol. 1992;229:83–9.PubMedCrossRef
22.
Ram Z, Sadeh M, Shacked I. Magnesium sulfate reverses experimental delayed vasospasm after subarachnoid hemorrhage in rats. Stroke. 1991;22:922–7.PubMed
23.
Higgins JPT, Green S (editors) (2009) Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration
24.
Dorhout Mees S, Rinkel GJE, Feigin VL, et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;3:CD000277.PubMed
25.
Jadad AR, Cook DJ, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA. 1998;280:278–80.PubMedCrossRef
26.
Schmid-Elsaesser R, Kunz M, Zausinger S, et al. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery. 2006;58(6):1054–65.PubMedCrossRef
Metadata
Title
Magnesium Sulfate Treatment Improves Outcome in Patients with Subarachnoid Hemorrhage: A Meta-analysis Study
Authors
Bin Huang
Nikan H. Khatibi
Linyan Tong
Pengcheng Yan
Peng Xie
John H. Zhang
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Translational Stroke Research / Issue 2/2010
Print ISSN: 1868-4483
Electronic ISSN: 1868-601X
DOI
https://doi.org/10.1007/s12975-010-0022-8

Other articles of this Issue 2/2010

Translational Stroke Research 2/2010 Go to the issue

Original Article

Effect of Hyperglycemia on Brain Penetrating Arterioles and Cerebral Blood Flow Before and After Ischemia/Reperfusion

Editorial Review

Inflammation After Stroke: Mechanisms and Therapeutic Approaches

ORIGINAL ARTICLE

Implications of Immune System in Stroke for Novel Therapeutic Approaches

EDITORIAL

Beyond Neuroprotection to Brain Repair: Exploring the Next Frontier in Clinical Neuroscience to Expand the Therapeutic Window for Stroke

OriginalPaper

Administration of a Sigma Receptor Agonist Delays MCAO-Induced Neurodegeneration and White Matter Injury

Review Article

Translational Stroke Research Using a Rabbit Embolic Stroke Model: A Correlative Analysis Hypothesis for Novel Therapy Development